Searchable
Answer one specific buyer question in the words buyers use, with the answer visible before the first scroll.

LIVE BUYER INTELLIGENCE
The VELUPLY Tissue Industry Question Radar monitors public buyer and operator discussions for recurring sourcing problems, then checks each problem against industry associations, standards owners and primary product documentation. Community posts reveal the question; they do not prove the answer. A topic becomes an article only when it is relevant to B2B tissue procurement, independently repeated, fact-checkable and meaningfully different from existing VELUPLY guidance.
BUYER CHECKLIST
The process deliberately separates voice-of-customer discovery from factual authority.
BUYER CHECKLIST
Topics are prioritized when they change quotation comparability, product fit, evidence quality or repeat-order risk.
DECISION POINTS
Answer one specific buyer question in the words buyers use, with the answer visible before the first scroll.
Keep source roles, access dates, evidence limits and direct links visible for search engines and AI answer systems.
Translate discussion into RFQ fields, comparison tables, sample checks and supplier questions.
WORKING SEQUENCE
Scan approved public sources for recent and recurring tissue questions.
Cluster near-duplicate questions and score buyer impact, commercial fit, search intent and evidence availability.
Verify technical statements with original or authoritative sources and record the claim boundary.
Check the topic against every existing VELUPLY page to prevent duplication and keyword cannibalization.
Publish no more than one qualified answer; publish nothing when the quality gate fails.
DIRECT ANSWERS
No. Public discussions are question and language signals only. Technical, legal, environmental and performance statements require separate verification.
No. It checks every day, but the publishing ceiling is zero or one article. No article is the correct outcome when sources are weak, the topic duplicates an existing page or VELUPLY cannot add a useful procurement answer.
No. A named manufacturer's claim remains limited to the cited product, dispenser, study and market. VELUPLY products need their own matched sample, specification and evidence.
A material source or specification change triggers review. The published and last-reviewed dates remain separate so a cosmetic edit cannot make an old article appear newly researched.